| Gene symbol | MUC1 | Synonyms | ADMCKD, ADMCKD1, ADTKD2, CA 15-3, CD227, Ca15-3, EMA, H23AG, KL-6, MAM6, MCD, MCKD, MCKD1, MUC-1, MUC-1/SEC, MUC-1/X, MUC1/ZD, PEM, PEMT, PUM | Type of gene | protein-coding |
| Chromosome | 1 | Map location | 1q22 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | ||||
| Description | mucin 1, cell surface associated | ||||
| GTO ID | GTC1568 |
| Trial ID | NCT02617134 |
| Disease | Brain Glioma | Stomach Cancer | Colorectal Carcinoma |
| Altered gene | MUC1 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | MUC-1 CAR-T cells |
| Phase | Phase1|Phase2 |
| Recruitment status | Unknown |
| Title | CAR-T Cell Immunotherapy in MUC1 Positive Solid Tumor |
| Year | 2015 |
| Country | China |
| Company sponsor | PersonGen BioTherapeutics (Suzhou) Co., Ltd. |
| Other ID(s) | PG-021-002 |
| Cohort 1 | |||||||||
|
|||||||||